symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NAUT,2.67,0.930241,70306,333565770,0,1.5-4.65,-0.02,"Nautilus Biotechnology, Inc.",USD,0001808805,US63909J1088,63909J108,NASDAQ Global Select,NASDAQ,Biotechnology,https://www.nautilus.bio,"Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.",Mr. Sujal M. Patel,Healthcare,US,153,206 333 2001,2701 Eastlake Avenue East,Seattle,WA,98102,,0,https://financialmodelingprep.com/image-stock/NAUT.png,2020-08-07,False,False,True,False,False
